ANVISA approved an additional indication for MINJUVI in Brazil for Knight Therapeutics' affiliate United Medical Ltda. The regulatory green light should modestly expand MINJUVI's addressable market in Brazil and could support incremental revenue and a small positive re-rating for Knight's shares.
ANVISA approved an additional indication for MINJUVI in Brazil for Knight Therapeutics' affiliate United Medical Ltda. The regulatory green light should modestly expand MINJUVI's addressable market in Brazil and could support incremental revenue and a small positive re-rating for Knight's shares.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
